VIRTUAL LEARNING SEMINAR
An Overview of Systemic Chemotherapy and the Acute and Late Side Effects of Treatment in the Oncology Population (1:17:32)
a seminar included in:
COURSE:Core Competencies in Interdisciplinary Cancer Rehabilitation
- Julia Osborne, PT, CLT-LANA - Physical Therapist | Oncology Rehabilitation Specialist | Lymphedema Specialist | Educator | Founder/Owner of Oncology Rehab-Centennial, Colorado | Founder/Owner of Physiological Oncology Rehabilitation Institute (PORi)
In the oncology population, chemotherapy is often a selected modality in the treatment of solid tumor and liquid cancers. In this presentation, the audience learns the purpose and categories of chemotherapy as well as where in the treatment trajectory chemotherapy is administered.
The audience will learn about the common side effects from systemic and targeted and immunotherapy, specifically myelosuppression, cardiotoxicity, chemotherapy induced peripheral neuropathy, cancer related fatigue, and cognitive changes. The presenter will explain common body system responses to cancer and cancer treatment and highlight specific precautions and contraindications.
The presenter will discuss general exercise guidelines and rehabilitation considerations with possible fluctuating laboratory values, side effects and compromise to body systems.
The educator relays the importance of the essential role that the interdisciplinary cancer care team has during a patient’s cancer care trajectory to address the acute, late and long-term effects of chemotherapy in order to minimize unnecessary suffering and optimize function and quality of life.
- Understanding the clinical profile of patients undergoing chemotherapy
- Describe the three main categories of chemotherapy
- Understand the differences of chemotherapy treatment design and use in treating oncology patients
- Identify relevant physiological and body system-based side effects that each group of chemotherapy agents elicit
- Integrate chemotherapy drug information into appropriate clinical patient profiles and pathways of treatment